Dispelling Myths and Misconceptions ACC/AHA 2013 Digoxin Guidelines for Heart Failure.

Slides:



Advertisements
Similar presentations
Preservation of Renal Function: The Key to Long-term Kidney Allograft and Patient Survival.
Advertisements

Emerging Concepts in Heart Failure
Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.
Statin Selection in the Elderly
Renal Denervation Two Late-Breaking Clinical Trials.
Acute Heart Failure.
US Guidelines US Guidelines Low-risk Patients.
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Heart Rate, HF Admissions, and Readmissions
The Nurse View.
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
Patient 1: 53-Year-Old Man With CVD Risk Factors
Hunter Syndrome: Why We Need to Diagnose and Treat Early
American Heart Association Scientific Sessions
PCP Perspectives Clinical Considerations in Hyperkalemia
Biosimilars in RA: A Blessing or a Curse?
Optimizing Outcomes in the Management of GIST
Resistant Hypertension
Before and After: Patient Cases in Onychomycosis
Program Goal. Program Goal Current Stroke Guidelines: AHA/ASA.
Surveying the Safety of NOACs in the Real World
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
HBV Infection: Some Sobering Facts
How Can we Improve Outcomes for the Elderly Patient with AML?
Assessing Disease Progression in MS Treatment
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
New Pathways in Lipid Care
What's New in Dyslipidemia?
PCP View: ACC/AHA Guidelines: Role of Moderate Intensity Statins
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Advances in the Management of Severe and Life-Threatening Chemotoxicity.
Management of Adolescents With Seizures
PCSK9 Inhibitors and Cardiovascular Outcomes
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Detecting and Treating Asparaginase-Related Toxicities in Acute Lymphoblastic Leukemia.
VTE in Cancer.
Reversal Strategies for VKA: Truths and Misconceptions
Program Goals Disclaimer Overview Assessing Disease Activity.
Poor Response to Initial Therapy for Migraine
Multidisciplinary Management of Hyperkalemia:
What's New on Interventions for Lower Limb Spasticity?
Updates in Heart Failure:
Preventing Clinical Events in PAH
What's New in Therapeutic Options for Moderate to Severe RA?
Challenging the Myths in Heart Failure With Reduced Ejection Fraction
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
Program Goals Disclaimers Defining Refractory Seizures.
Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.
Current Challenges in Managing Hemophilia
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Managing Pulmonary Embolism Posthospital Discharge
Iron Deficiency in Heart Failure
Challenges in LA SCCHN.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Clinical Challenges and Updates in Managing Seizure Clusters
Navigating New Treatment Landscapes in HR+ HER2-Negative Advanced Breast Cancer.
Selecting Treatment Approaches in Hemophilia
Issues in Patients With Severe Epilepsy
VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.
Binge Eating Disorder.
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Real-World Data in Cardiology: Focus on Atrial Fibrillation
The Building Blocks of Homocystinuria and Homocysteinemia Management
ESC Guideline on the Management of STEMI Recommendation for DAPT
My PAH Patient.
Key Data on Improving Outcomes in HF Patients
Extraordinary Cases in Stroke Prevention
Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.
Shared-Decision Making in Dyslipidemia
Presentation transcript:

Dispelling Myths and Misconceptions

ACC/AHA 2013 Digoxin Guidelines for Heart Failure

Guidelines From the ADHERE REGISTRY

Use of Digoxin in Contemporary Studies and Registries

Digoxin Toxicity as an Ongoing Clinical Challenge

Digoxin Toxicity

Digoxin Toxicity Outcomes

Understanding the Pharmacology of Digoxin

Digoxin Laboratory Values Survey

Signs of Digoxin Toxicity

Treatment Options

Digoxin-specific Antibody Fragments

Digoxin-specific Antibody Fragments

Acute Life-threatening Digoxin Overdose

Digoxin-specific Antibody Fragments

Digoxin Toxicity Is Underrecognized!

Education and Prevention

Digoxin Dosages and Serum Concentrations Nontoxic and Toxic Therapeutic Ranges

Key Take-away Points

Summary

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)